Callan JMB (CJMB) - EV/EBITDA Multiple
Callan JMB Inc (CJMB) faces slow implementation of new systems in clinics and patent threats. The company's financial stability is based on long-term agreements with hospitals, ensuring moderate growth in flows. This chart of share price dynamics through the lens of EV/EBITDA is 0.00. The business's future market success relies on passing certification and gaining physician approval, which will solidify its technological potential.
Analytical breakdowns for callanjmb.com (CJMB)
- stock price and consensus target price:
- market capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
- business earnings and investment ratios data:
CJMB - Company Net Income|Expected Profit Callan JMB Inc|CJMB - Price to Earnings Multiple|Projected Price to Earnings Callan JMB|CJMB - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CJMB|CJMB - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Callan JMB|CJMB - Net earnings per share for the last 12 months|Quarterly EPS earnings growth callanjmb.com|CJMB - Earnings growth in current year|Net earnings per share growth forecast for next year Callan JMB Inc
Summary company analysis:Callan JMB Corp (CJMB)
Conservative investors must understand whether a business can service its debt amidst profit volatility. For Callan JMB (CJMB), which is scaling the production of high-precision surgical instruments, this parameter determines the capital safety margin during its expansion period. By analyzing the historical EV/EBITDA chart for Callan JMB (CJMB), we compare the total enterprise value with its operating efficiency to assess the risk of overpaying for the asset.
Competitors of Callan JMB Inc
Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TFX (Teleflex Incorporated)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista NVST|Business Value to Operating Income Before Depreciation ICUI|XRAY: Enterprise Value to EBITDA Ratio|LMAT - EV/EBITDA Multiple|AtriCure, Inc. (ATRC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio staar.com|NAGE (ChromaDex Corp.) - EV/EBITDA Multiple|Company Value to EBITDA ZimVie Inc ZIMV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AngioDynamics Corp (ANGO)|Cerus Inc - Enterprise Value to Operating Income Before Depreciation|Alpha Teknova, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio MGRM (monogramorthopedics.com)|STSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio InfuSystem Holdings INFU|UTMD: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio KORU Medical|NYXH (Nyxoah S.A.) - EV/EBITDA Multiple|EV/EBITDA Multiple microbotmedical.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pro-Dex (PDEX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ZTEK (Zentek Ltd)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Elutia Corp ELUT|Milestone Scientific Corporation - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|NEXGEL, Inc. - EV/EBITDA Multiple|RVP - EV/EBITDA Multiple|Harvard Bioscience (HBIO) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation FEMY|Enterprise Value to EBITDA Ratio MHUA|POAI: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Atrion Corporation (ATRI)|Enterprise Value to Operating Income Before Depreciation Ratio NURO
